| Sheena B Patel, OD | |
|
44569 Schoenherr Rd, Sterling Heights, MI 48313-1133 | |
| (586) 726-0515 | |
| Not Available |
| Full Name | Sheena B Patel |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 8 Years |
| Location | 44569 Schoenherr Rd, Sterling Heights, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376092486 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4901005018 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| J. Leung Pllc | 3173683232 | 2 |
News Archive
PharmaDirections congratulates Orexigen Therapeutics on achieving FDA Advisory Board approval for their anti-obesity drug Contrave™. PharmaDirections is proud to have been Orexigen's pharmaceutical development partner and to have developed and produced the first Contrave™ product to undergo full clinical development.
In a new article published in the journal Molecular Neurodegeneration, researchers at the University of Missouri School of Medicine take some of the first steps toward unraveling the molecular dysfunction that occurs when proteins are exposed to environmental toxins. Their discovery helps further explain recent NIH findings that demonstrate the link between Parkinson's disease and two particular pesticides - rotenone and paraquat.
TVM Capital MENA today announced that it has received the approval of the Dubai Financial Services Authority (DFSA) to start operation of its first regional healthcare growth capital fund with US$40 million of subscriptions from founding investors, Saudi Health Investment Company (SHIC), the International Finance Corporation (IFC), and GE Healthcare. TVM Capital MENA Ltd., the fund's operator, is based in the Dubai International Financial Centre (DIFC) and is licensed and regulated by the DFSA.
On the evening of March 4, 2010, the U.S. Senate passed a resolution designating March as "National Autoimmune Diseases Awareness Month" and supporting efforts to increase awareness of autoimmune diseases and increase funding for autoimmune disease research. The Senate resolution (S.RES.372) was introduced by Michigan Senator Carl Levin on December 8, 2009.
› Verified 5 days ago
| Provider Name | J. Leung Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1285880401 PECOS PAC ID: 3173683232 Enrollment ID: O20081119000155 |
News Archive
PharmaDirections congratulates Orexigen Therapeutics on achieving FDA Advisory Board approval for their anti-obesity drug Contrave™. PharmaDirections is proud to have been Orexigen's pharmaceutical development partner and to have developed and produced the first Contrave™ product to undergo full clinical development.
In a new article published in the journal Molecular Neurodegeneration, researchers at the University of Missouri School of Medicine take some of the first steps toward unraveling the molecular dysfunction that occurs when proteins are exposed to environmental toxins. Their discovery helps further explain recent NIH findings that demonstrate the link between Parkinson's disease and two particular pesticides - rotenone and paraquat.
TVM Capital MENA today announced that it has received the approval of the Dubai Financial Services Authority (DFSA) to start operation of its first regional healthcare growth capital fund with US$40 million of subscriptions from founding investors, Saudi Health Investment Company (SHIC), the International Finance Corporation (IFC), and GE Healthcare. TVM Capital MENA Ltd., the fund's operator, is based in the Dubai International Financial Centre (DIFC) and is licensed and regulated by the DFSA.
On the evening of March 4, 2010, the U.S. Senate passed a resolution designating March as "National Autoimmune Diseases Awareness Month" and supporting efforts to increase awareness of autoimmune diseases and increase funding for autoimmune disease research. The Senate resolution (S.RES.372) was introduced by Michigan Senator Carl Levin on December 8, 2009.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sheena B Patel, OD 44569 Schoenherr Rd, Sterling Heights, MI 48313-1133 Ph: () - | Sheena B Patel, OD 44569 Schoenherr Rd, Sterling Heights, MI 48313-1133 Ph: (586) 726-0515 |
News Archive
PharmaDirections congratulates Orexigen Therapeutics on achieving FDA Advisory Board approval for their anti-obesity drug Contrave™. PharmaDirections is proud to have been Orexigen's pharmaceutical development partner and to have developed and produced the first Contrave™ product to undergo full clinical development.
In a new article published in the journal Molecular Neurodegeneration, researchers at the University of Missouri School of Medicine take some of the first steps toward unraveling the molecular dysfunction that occurs when proteins are exposed to environmental toxins. Their discovery helps further explain recent NIH findings that demonstrate the link between Parkinson's disease and two particular pesticides - rotenone and paraquat.
TVM Capital MENA today announced that it has received the approval of the Dubai Financial Services Authority (DFSA) to start operation of its first regional healthcare growth capital fund with US$40 million of subscriptions from founding investors, Saudi Health Investment Company (SHIC), the International Finance Corporation (IFC), and GE Healthcare. TVM Capital MENA Ltd., the fund's operator, is based in the Dubai International Financial Centre (DIFC) and is licensed and regulated by the DFSA.
On the evening of March 4, 2010, the U.S. Senate passed a resolution designating March as "National Autoimmune Diseases Awareness Month" and supporting efforts to increase awareness of autoimmune diseases and increase funding for autoimmune disease research. The Senate resolution (S.RES.372) was introduced by Michigan Senator Carl Levin on December 8, 2009.
› Verified 5 days ago
Dr. Edmon Georges, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 44569 Schoenherr Rd, Sterling Heights, MI 48313 Phone: 586-726-0515 | |
Dr. Daniel Flick, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 43910 Schoenherr Rd, Sterling Heights, MI 48313 Phone: 586-247-5910 Fax: 586-247-5920 | |
Eyesee Eyecare L.l.c Optometrist Medicare: Medicare Enrolled Practice Location: 37522 Dequindre Rd, Sterling Heights, MI 48310 Phone: 586-737-3937 | |
Miller Optical Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 43560 Van Dyke Ave, Sterling Heights, MI 48314 Phone: 586-254-9600 Fax: 586-254-6787 | |
Michigan Optometry Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 33201 Van Dyke Ave, Sterling Heights, MI 48312 Phone: 586-939-8204 Fax: 586-939-8202 | |
Mark Alan Schwartz, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 13400 E 15 Mile Road, Sterling Heights, MI 48312 Phone: 586-939-1122 Fax: 586-939-9328 | |
Svs Vision Optical Centers Optometrist Medicare: Not Enrolled in Medicare Practice Location: 36824 Van Dyke Ave, Sterling Heights, MI 48312 Phone: 586-276-9300 Fax: 586-261-5094 |